This investigation was initiated in order to delineate the structure-f
unction relationship of the anticancer alkyl-lysophospholipids and ass
ess their degree of selective cytotoxicity toward neoplastic cells. A
series of glycerol phosphocholine analogs with varying substitutions i
n the sn-1 and sn-2 position were tested for their inhibitory activity
as measured by thymidine incorporation, clonogenic assays and effects
on protein kinase C activity against a series of human leukemic cell
lines and healthy bone marrow progenitor cells. The IC50 was determine
d for each of the compounds in each cell line and healthy bone marrow
cells following a 4-h incubation. The data indicated that a 16-18 carb
on chain at the sn-1 coupled with a short substitution at sn-2 had the
broadest antitumor activity and was the least toxic to normal bone ma
rrow cells. The results provide a number of useful leads toward the de
sign and development of potentially more active phospholipid compounds
.